Xeris Pharmaceuticals (XERS) IPO Opens 5% Higher

Today's IPO for Xeris Pharmaceuticals, Inc. (NASDAQ: XERS) opened for trading at $15.75 after pricing 5,700,000 shares of common stock at a public offering price of $15.00 per share.

The Company has also granted the underwriters a 30-day option to purchase from the Company up to an additional 855,000 shares of common stock at the initial public offering price, less the underwriting discount.

Jefferies, Leerink Partners, RBC Capital Markets and Mizuho Securities are acting as joint book running managers for the proposed offering.

Xeris Pharmaceuticals is a specialty pharmaceutical company leveraging its novel formulation technology platforms to develop and commercialize ready-to-use, room-temperature stable injectable and infusible drug formulations.

You May Also Be Interested In

• OpenAI revenue chief quits after less than a year
• Robinhood's second fund for retail investors eyeing private markets starts trading
• Nexon Releases Earnings for Second Quarter 2026